Garnet Equity Capital Holdings, Inc. Bristol Myers Squibb CO Transaction History

Garnet Equity Capital Holdings, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$53.63 - $62.52 $2.15 Million - $2.5 Million	-40,000 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$59.17 - $69.31 $2.37 Million - $2.77 Million	40,000 New	40,000 $2.72 Million
Q3 2020 Nov 04, 2020	SELL	$57.43 - $63.64 $3.45 Million - $3.82 Million	-60,000 Closed	0 $0
Q2 2020 Aug 04, 2020	BUY	$54.82 - $64.09 $1.1 Million - $1.28 Million	20,000 Added 50.0%	60,000 $3.53 Million
Q1 2020 May 05, 2020	SELL	$46.4 - $67.43 $928,000 - $1.35 Million	-20,000 Reduced 33.33%	40,000 $2.23 Million

Q4 2019 Jan 14, 2020	BUY	$49.21 - $64.19 $2.95 Million - $3.85 Million	60,000 New	60,000 $3.85 Million
Q1 2018 Apr 18, 2018	SELL	$59.92 - $68.98 $3.6 Million - $4.14 Million	-60,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $3.6 Million - $3.92 Million	60,000	60,000 $3.68 Million

2,553

1.49B

25.9M

20M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $86B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Garnet Equity Capital Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Garnet Equity Capital Holdings, Inc. with notifications on news.